Biogen Inc
SWB:IDP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Biogen Inc
SWB:IDP
|
US |
|
W
|
Wisekey International Holding AG
F:1W8
|
CH |
|
V
|
Verizon Communications Inc
XBER:BAC
|
US |
|
Nextensa NV
LSE:0NUT
|
BE |
|
Stem Inc
NYSE:STEM
|
US |
|
G
|
Goldstar Minerals Inc
OTC:GDMIF
|
CA |
|
A
|
Aegon NV
XHAM:AEND
|
NL |
|
Powszechna Kasa Oszczednosci Bank Polski SA
LSE:0FMO
|
PL |
|
Sappi Ltd
F:SPI
|
ZA |
|
Bloom Energy Corp
LSE:0A4L
|
US |
|
Syra Health Corp
OTC:SYRA
|
US |
|
E
|
Exelon Corp
BMV:EXC
|
US |
|
L
|
Larimar Therapeutics Inc
F:ZA71
|
US |
|
W
|
WEX Inc
SWB:WL9
|
US |
|
Hoya Corp
OTC:HOCPF
|
JP |
|
I
|
Inseego Corp
F:INO
|
US |
|
I
|
Insurance Australia Group Ltd
OTC:IAUGF
|
AU |
|
R
|
Reliance Home Finance Ltd
BSE:540709
|
IN |
|
C
|
Compass Inc
F:91D
|
US |
Bankruptcy Probability
Biogen Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Biogen Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Biogen Inc
NASDAQ:BIIB
|
28.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
166.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
376.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
181.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
67.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
43B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
39.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Biogen Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Biogen Inc has total debt of 6.3B USD. This includes both short-term (0 USD) and long-term (6.3B USD) debt.
You can find a full breakdown on its Balance Sheet.
